The New Year festivities may be upon us but the market chugs along nonetheless and investors are going to continue to look for stocks worth investing in.
Trading Data
On Wednesday, THCT stock fell 4.55% to $0.1050 with more than 59k shares, compared to its average volume of 62k shares. The stock has moved within a range of $0.1000 – 0.1200 after opening trade at $0.12.
Kevin Bell CO-Founder & CEO of Kali Partners/VP of Tyson 2.0 joins THC Therapeutics
One of the stocks that you could look into at this point in time is that of THC Therapeutics Inc (OTCMKTS:THCT), which has emerged as a major gainer over the past week and managed to clock gains of as much as 40% during the period. It is an innovative technology company that seeks to provide ‘better health through the science of nature’. Yesterday, the company was in the news after it made a major announcement.
THC Therapeutics announce yesterday that it had entered into a consulting agreement with the firm Five Points Consulting, which is owned by Kevin Bell and Edward Culhane. Five Points Consulting is going to responsible for the identification of growth opportunities for THC Therapeutics and help in executing the plans.
It goes without saying that it was a significant announcement from the company and one that could help in the company’s growth in the long term. It might be a good idea for investors to add the stock to their watch lists and keep an eye on it.
Key Quote
“THC Therapeutics is well positioned to exploit inefficiencies and capitalize on emerging opportunities in Cannabis and Psychedelicsindustries. I look forward to taking the company to the next level and growing revenue and increasing value for investors,” said Bell.
Technical Data
THCT stock is trading above the 20-Day and 50-Day Moving averages of $0.10 and $0.13 respectively. Moreover, the stock is above 200-Day moving average of $0.18.
